Clinical Trials

    Here are the clinical trials currently open for subject enrollment:

    HS# 2012-8724: A Phase 0, Open Label, Non-Randomized, Multi-Center, Exploratory and Safety Study of [F-18]T808
    HS# 2012-8723: A Phase 0, Open Label, Non-Randomized, Multi-Center, Exploratory and Safety Study of [F-18]T807
    HS# 2012-8714: Development of a Quantitative Tissue Optical Index of Breast Density for Prediction of Hormone Therapy Response
    HS# 2011-8148: Correlation of Clinical and MRI Findings with Prognosis of Breast Cancer Patients
    HS# 2011-8112: Prostate MRI for High-Risk Patients
    HS# 2011-8082: An Exploratory, Open Label, Non-randomized, Multi Center Study of [F-18] CP-18
    HS# 2008-6346: Analysis of Imaging Features of Breast Diseases and Breast Density Evaluated on Mammogram, Ultrasound and MRI Collected in a Database
    HS# 2007-6084: A Phase II Study of Breast Cancer Treatment Using Weekly Carboplatin+Nab-paclitaxel, plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
    HS# 2006-5162: Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
    HS# 2002-2611: Magnetic Resonance Imaging and Spectroscopy at High Field

    These human subject protocols are currently active, but they are closed for subject enrollment:


    HS# 2010-7494: A Phase II, Open Label, Non-Randomized, Multi-Center, Pilot, Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as A Tool to Monitor Response to An Anti-Angiogenic Drug
    HS# 2009-7024: A PHASE 0, OPEN LABEL, NON-RANDOMIZED, MULTI CENTER, EXPLORATORY AND SAFETY STUDY OF [F-18] W372
    HS# 2009-6905: Developing A Computer-Aided Diagnostic System for Alzheimer’s Disease
    HS# 2004-3681: Phase II Chemoprevention Trial - Anastrozole in the DCIS and Early Invasive Breast Cancer in Postmenopausal Women